Craniopharyngioma is a rare type of brain tumor, typically benign, but challenging to treat due to its location near critical structures in the brain. Research in cancer treatment for craniopharyngioma focuses on innovative approaches to mitigate side effects and improve outcomes. Novel therapies such as targeted drug delivery systems and immunotherapy are being explored to minimize damage to surrounding tissues while effectively targeting tumor cells. Additionally, advancements in imaging techniques aid in precise tumor localization for surgical removal, reducing the risk of recurrence. Collaborative efforts between clinicians, researchers, and pharmaceutical companies aim to develop personalized treatment strategies tailored to the specific genetic and molecular characteristics of each patient's tumor, offering hope for improved prognosis and quality of life.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States